このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

4 歳から 12 歳までの子供を持つ親と、アルコール使用障害を持つ 1 人の親における子育てプログラムの実施の評価 (APPROCHILD)

2026年9月28日 更新者:University Hospital, Brest

Alcohol use disorders are a major public health problem in Europe. The average prevalence of Alcohol Use Disorders (AUD) in the general population is 7.5%, although there are large variations between countries. According to the literature, 20 to 30% of children have parents with problematic alcohol use. Public health authorities are alarmed by the precociousness of alcohol consumption in the youngest age and by the prevalence of alcohol consumption in adolescence. One of the well-established risk factors for alcohol use and abuse is having a parent with AUD. Compared with people growing up without any parent with AUD, the relative risk of suffering negative life events in childhood is 2 to 13 times higher if one or both parents have alcohol use disorders. A family history of Alcohol Use Disorders is predictive of earlier alcohol, tobacco, or cannabis use in adolescence, but it is also associated with a higher risk of developing substance use disorders.

調査の概要

状態

募集

詳細な説明

Despite these alarming data, very few studies have focused on preventing alcohol use in vulnerable populations with at least one parent with Alcohol Use Disorders. Parenting support programs have been developed, according to current knowledges, there are no programs in French that target families with Alcohol Use Disorders.

The EQUIPE program is a French adaptation of the Canadian program, Community Parent Education (COPE). It is a psycho-educational intervention program developed́ by C. Cunningham (McMaster University, Hamilton, ON). It is aimed at improving parenting skills. Its format involves a 2 hr/week session and is spread over 10 weeks. During the sessions, using short video vignettes, parents are encouraged to find their own solutions to difficulties in managing their child's behaviour. These solutions are then discussed among parents in the presence of professionals (animators or facilitators). Finally, educational strategies are adopted and practiced in the family setting. This program aims to strengthen the protective factors of children in the face of risky behaviours that they may develop during adolescence, by having parents and children work together on communication, the establishment of warm and positive relationships and their ability to resolve problems and conflicts. This EQUIPE program has been evaluated in Quebec with families experiencing difficulties with children with behavioral problems. At present, in France, no parenting support program is applied to families with addictive behaviors in a broad and evaluated manner. The investigators believe that an "early" intervention could allow to apprehend future social and mental problems (malaise and depression, school dropout, delinquency...), and limit the risks of intra-family conflicts and thus reduce the negative impact on the potential development of psychological disorders and addictive behaviors in adolescence and adulthood. The implementation of this parenting support program, applied to families suffering from alcohol addictive behaviors and at an early stage with children aged 3-12 years, would seem to be relevant in order to reinforce parenting skills.

研究の種類

介入

入学 (推定)

90

段階

  • 適用できない

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究連絡先

研究場所

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

18年歳以上 (大人、高齢者)

健康ボランティアの受け入れ

いいえ

受講資格のある性別

全て

説明

Inclusion Criteria :

  • Major subject (age > 18 years)
  • Patient with a child between 4 and 12 years old
  • Patient living with his/her child permanently or partially
  • Patient or his/ her spouse with an alcohol use disorder (at least 3 of the 11 DSM 5 criteria for alcohol use disorder in the past 12 months)
  • Written and informed consent

Exclusion Criteria :

  • Minor subject (age < 18 years)
  • Acute, unstabilized psychiatric disorder impairing judgment
  • Incapacity or refusal to give consent
  • Subject under judicial protection or family habilitation
  • Subject deprived of liberty by judicial or administrative decision, under guardianship or curatorship ;
  • Non comprehension of the French language

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:防止
  • 割り当て:なし
  • 介入モデル:単一グループの割り当て
  • マスキング:なし(オープンラベル)

武器と介入

参加者グループ / アーム
介入・治療
実験的:エキッププログラム

EQUIPE is a manualised group community-based parent education programme. Groups consist of 15 parents who meet with one or two trained group leaders for weekly 2-hour sessions over 10 weeks.

This program promotes skill development in parents, strengthens relationships with children, increases cooperation, and helps solve problems in the home.

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Effectiveness of a parenting program
時間枠:At 6 month post EQUIPE program

Overall score measuring the level of parental stress, obtained using the Parental Stress Index (PSI), measured at the post-inclusion visit and at the 6-month post-program visit.

Parental Stress Index was designed to evaluate the magnitude of stress in the parent-child system, with 101-item inventory that focuses on two major domains of stress: child characteristics and parent characteristics.

The score is obtained by summing the responses to the items and then converting it to a percentile. A high score means that the parent is stressed.

At 6 month post EQUIPE program

二次結果の測定

結果測定
メジャーの説明
時間枠
Score on the different domains of the Parental Stress Index
時間枠:At 6 month post EQUIPE program

The different domains of the Parental Stress Index were :

  • Within the Child Domain, six subscales (Distractibility/Hyperactivity, Adaptability, Demandingness, Reinforces Parent, Acceptability and Mood)
  • Within the Parent Domain, seven subscales (Competence, Isolation, Attachment, Health, Role Restriction, Depression, and Spouse/Parenting Partner Relationship)
  • The Total Stress scale is combined of the two domains (Child and Parent).
At 6 month post EQUIPE program
Evaluation of self-esteem
時間枠:At 3, 6 and 12 month post EQUIPE program

Self-esteem is evaluated by the Rosenberg scale. The Rosenberg Self-Esteem Scale measures overall self-confidence by measuring both positive and negative feelings. The scale has 10 items. Each item is measured on a scale of 1 to 4, from strongly disagree for 1 to strongly agree for 4.

At 3, 6 and 12 month post EQUIPE program
Evaluation on children's behaviors
時間枠:At 3, 6 and 12 month post EQUIPE program

For assessed the impact on children's behaviors, Strengths and Difficulties Questionnaire (SDQ) was used. SDQ is a questionaire which used for mental health problems screening in children. This questionnaire measures the presence of behaviours that indicate emotional difficulties such as physical aggression, isolation, anxiety, difficulty concentrating and impulsivity. It is intended for children from 3 to 16 years old and can be completed by the parent. SDQ includes 25 questions that the parent can answer with "not true", "somewhat true" or "very true". The score is obtained as follows: for each statement, the answer "false" gives zero points, "somewhat true" one point and "absolutely true" two points. With the exception of the items marked in bold, for which the "false" answer gives two points and the "absolutely true" answer zero, the other option remains the same. Emotional or behavioral difficulties are considered to exist when the score is 16 or higher.

At 3, 6 and 12 month post EQUIPE program
Evaluation of alcohol use
時間枠:At 3, 6 and 12 month post EQUIPE program

Alcohol consumption measured by the Alcohol Timeline Followback (ATLFB) score at each visit. The A-TLFB is a method of assessing alcohol consumption that provides an estimate of the daily amount of alcohol consumed in standard units.It has been evaluated in clinical and non-clinical populations and in adults and adolescents. It is in the form of a calendar. Respondents report their daily alcohol consumption over a specified period of the past 30 days. Recall aids can be used during the completion of the questionnaire (dates, events, etc.). This tool has good psychometric qualities and is recommended when precise information on the quantities of alcohol consumed or the number of days of consumption is needed.

It allows to identify the number of days of alcohol consumption in the month and the number of days with alcohol consumption above 5 standard units/d.

No score is obtained but we have the follow-up of the patients' consumption

At 3, 6 and 12 month post EQUIPE program
Evaluation of severity of alcohol use disorders
時間枠:At 3, 6 and 12 month post EQUIPE program

Severity of alcohol use disorders at each visit, as measured by the number of Diagnostic and Statistical manual of Mental disorders 5 (DSM5) criteria. The DSM5 score is diagnosis of addiction is based on well-defined criteria set out in the Diagnostic and Statistical manual of Mental disorders (DSM), the fifth edition of which was published in 2013. The questionnaire consists of 11 items (diagnostic criteria for substance use disorders from the American Psychiatric Association's DSM V). The presence of 2 to 3 criteria: low addiction / Presence of 4 to 5 criteria: moderate addiction / Presence of 6 or more criteria: severe addiction.

At 3, 6 and 12 month post EQUIPE program
Evaluation of the progression of anxiety and depressive symptoms
時間枠:At 3, 6 and 12 month post EQUIPE program

Evaluation of the progression of anxiety and depressive symptoms This evolution will be assessed by Hopkins Symptom Checklist (HSCL25). The HSCL-25 is a questionnaire, consisting of 25 questions relating to the presence and intensity of symptoms of anxiety (question ranging from 1 to 10) and depression (question ranging from 11 to 25) during the last full week. The patient is asked to rate each item on a four-point scale, ranging from 1: strongly disagree, to 4: strongly agree. To obtain the diagnostic score, the responses to all questions are summed and divided by 25.

At 3, 6 and 12 month post EQUIPE program
Evaluation of the quality of life during the follow-up time
時間枠:At 3, 6 and 12 month post EQUIPE program

Quality of life evaluated by the World Health Organization Quality of Life (WHOQOL scale brief). The WHOQOL-BREF instrument consists of 26 items that measure the following broad domains: physical health, psychological health, social relationships and environment. It is used to assess the quality of life of adults.

Each question is scored on a 5-point Likert scale (1 to 5). The sum of the points gives us the score. The higher the score, the better the patient's quality of life

At 3, 6 and 12 month post EQUIPE program
Evaluation of acceptability of the study by the participants
時間枠:At 3 month post EQUIPE program

Acceptability will be assessed using a Likert scale that asks individuals about their level of agreement or disagreement with a statement. The question "Do you think your participation in the EQUIPE program was useful to you?" will be asked at the end of the program.

Free comments will be left open with a question "Do you have any comments on the program?"

At 3 month post EQUIPE program

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

スポンサー

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (実際)

2024年2月22日

一次修了 (推定)

2028年2月22日

研究の完了 (推定)

2029年8月22日

試験登録日

最初に提出

2022年8月4日

QC基準を満たした最初の提出物

2022年8月4日

最初の投稿 (実際)

2022年8月5日

学習記録の更新

投稿された最後の更新 (実際)

2026年10月1日

QC基準を満たした最後の更新が送信されました

2026年9月28日

最終確認日

2026年9月1日

詳しくは

本研究に関する用語

キーワード

その他の研究ID番号

  • 29BRC20.0173

個々の参加者データ (IPD) の計画

個々の参加者データ (IPD) を共有する予定はありますか?

はい

IPD プランの説明

All collected data that underlie results in a publication.

IPD 共有時間枠

Data will be available beginning 42 month and ending 15 years following the final study report completion.

IPD 共有アクセス基準

Data access requests will be reviewed by the internal committee of BrestUH. Requestors will be required to sign and complete a data access agreement.

IPD 共有サポート情報タイプ

  • STUDY_PROTOCOL

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する